{
    "hands_on_practices": [
        {
            "introduction": "A cornerstone of evidence-based diagnosis is understanding how a test performs in a real-world population. While sensitivity and specificity describe a test's intrinsic accuracy, its clinical utility is captured by predictive values, which are critically dependent on the prevalence of the disease. This exercise  will guide you through the use of natural frequencies, a powerful and intuitive method that translates abstract probabilities into concrete patient numbers, helping you to grasp the tangible impact of prevalence on a test's positive predictive value (PPV).",
            "id": "4814913",
            "problem": "A hospital-based screening program in internal medicine is evaluating a mammography test for breast cancer in a cohort of $1000$ asymptomatic women aged $50$ to $69$. The disease prevalence in this cohort is $10/1000$. The test has sensitivity $0.90$ and specificity $0.95$. Use natural frequency reasoning to determine the expected counts per $1000$ screened for the following quantities and then the diagnostic value:\n- The expected number of true positives per $1000$.\n- The expected number of false positives per $1000$.\n- The positive predictive value (PPV), defined as the probability that a patient has the disease given a positive test, expressed as a decimal.\n\nYour calculation must start from fundamental definitions of prevalence, sensitivity, specificity, and conditional probability, and proceed by constructing the corresponding $2 \\times 2$ table in terms of counts per $1000$. Report the expected counts as exact values (these may be fractional). Express the PPV as a decimal rounded to four significant figures. For units, report counts per $1000$ screened individuals and PPV as a unitless decimal. Provide your final answer as a row matrix in the order $\\big($true positives per $1000$, false positives per $1000$, PPV$\\big)$.",
            "solution": "The problem is valid as it is scientifically grounded in standard epidemiological principles, well-posed with sufficient and consistent data, and objectively stated.\n\nThe problem asks for the determination of key diagnostic test metrics for a mammography screening program using a natural frequency approach. We are given a cohort of $N=1000$ asymptomatic women.\n\nLet $D^+$ denote the event that a woman has breast cancer, and $D^-$ denote the event that she does not. Let $T^+$ be the event of a positive test result and $T^-$ be the event of a negative test result.\n\nThe givens are:\n- Total number of individuals in the cohort: $N = 1000$.\n- Prevalence of the disease: $P(D^+) = \\frac{10}{1000} = 0.01$.\n- Sensitivity of the test: $\\text{Sens} = P(T^+ | D^+) = 0.90$.\n- Specificity of the test: $\\text{Spec} = P(T^- | D^-) = 0.95$.\n\nWe will construct a $2 \\times 2$ contingency table with expected counts out of the total cohort of $1000$.\n\nFirst, we determine the number of women in the cohort who have the disease and who do not.\nThe expected number of women with the disease ($N_{D^+}$) is:\n$$N_{D^+} = N \\times P(D^+) = 1000 \\times \\frac{10}{1000} = 10$$\nThe expected number of women without the disease ($N_{D^-}$) is:\n$$N_{D^-} = N - N_{D^+} = 1000 - 10 = 990$$\n\nNext, we calculate the number of true positives (TP), false negatives (FN), false positives (FP), and true negatives (TN).\n\nA true positive is a diseased individual who tests positive. The expected number of true positives ($TP$) is calculated using the sensitivity:\n$$TP = N_{D^+} \\times \\text{Sens} = 10 \\times 0.90 = 9$$\nThis is the first quantity requested: the expected number of true positives per $1000$ is $9$.\n\nA false negative is a diseased individual who tests negative. The expected number of false negatives ($FN$) is:\n$$FN = N_{D^+} \\times (1 - \\text{Sens}) = 10 \\times (1 - 0.90) = 10 \\times 0.10 = 1$$\n\nA false positive is a non-diseased individual who tests positive. The rate of false positives is $1 - \\text{Specificity}$.\n$$1 - \\text{Spec} = 1 - 0.95 = 0.05$$\nThe expected number of false positives ($FP$) is:\n$$FP = N_{D^-} \\times (1 - \\text{Spec}) = 990 \\times 0.05 = 49.5$$\nThis is the second quantity requested: the expected number of false positives per $1000$ is $49.5$.\n\nA true negative is a non-diseased individual who tests negative. The expected number of true negatives ($TN$) is:\n$$TN = N_{D^-} \\times \\text{Spec} = 990 \\times 0.95 = 940.5$$\n\nWe can summarize these expected counts in a $2 \\times 2$ table:\n$$\n\\begin{array}{c|cc|c}\n & \\text{Disease } (D^+) & \\text{No Disease } (D^-) & \\text{Total} \\\\\n\\hline\n\\text{Test Positive } (T^+) & TP = 9 & FP = 49.5 & 58.5 \\\\\n\\text{Test Negative } (T^-) & FN = 1 & TN = 940.5 & 941.5 \\\\\n\\hline\n\\text{Total} & 10 & 990 & 1000\n\\end{array}\n$$\n\nThe final quantity to calculate is the positive predictive value (PPV). The PPV is the probability that a patient with a positive test result actually has the disease, which is $P(D^+|T^+)$. This is calculated as the ratio of true positives to the total number of positive tests.\nThe total number of positive tests is the sum of true positives and false positives:\n$$\\text{Total Positives} = TP + FP = 9 + 49.5 = 58.5$$\nTherefore, the PPV is:\n$$PPV = \\frac{TP}{TP + FP} = \\frac{9}{58.5}$$\nNow, we compute the decimal value and round to four significant figures:\n$$PPV = \\frac{9}{58.5} \\approx 0.15384615...$$\nRounding to four significant figures gives $0.1538$.\n\nThe final results are:\n- Expected number of true positives per $1000$: $9$.\n- Expected number of false positives per $1000$: $49.5$.\n- Positive predictive value (PPV): $0.1538$.",
            "answer": "$$\\boxed{\\begin{pmatrix} 9 & 49.5 & 0.1538 \\end{pmatrix}}$$"
        },
        {
            "introduction": "While predictive values are useful for population-level insights, clinical practice demands a method to update diagnostic probability for the individual patient in front of you. Likelihood ratios (LRs) provide this by separating a test's characteristics from the pre-test probability, allowing for dynamic and patient-specific reasoning. In this problem , you will apply the odds-based form of Bayes' theorem to see how a test result with known LRs can quantitatively shift your diagnostic certainty, moving from a general suspicion to a refined, post-test probability.",
            "id": "4814989",
            "problem": "A 62-year-old patient presents with chest discomfort and diaphoresis. Based on clinical assessment incorporating history, electrocardiogram findings without ST-segment elevation, and risk factors, the pretest probability for non–ST-elevation myocardial infarction is estimated as $p(D)=0.20$, where $D$ denotes the presence of disease. You order a high-sensitivity cardiac troponin assay. The assay’s performance characteristics in this clinical context have been validated, with a likelihood ratio for a positive test $\\text{(LR+)}=8$ and a likelihood ratio for a negative test $\\text{(LR-)}=0.2$. Starting strictly from Bayes’ theorem and the core definitions of pretest probability, odds, and likelihood ratios, derive the posterior probabilities $p(D\\mid T^{+})$ and $p(D\\mid T^{-})$, where $T^{+}$ and $T^{-}$ denote a positive and negative test result, respectively. Express both posterior probabilities as decimals and round each to four significant figures. Then, interpret how these results should influence decisions about further testing versus immediate management, assuming standard internal medicine practice patterns for suspected acute coronary syndromes.",
            "solution": "The problem statement has been validated and is determined to be sound, well-posed, objective, and scientifically grounded in the principles of Bayesian inference as applied to medical diagnostics. All necessary data are provided, and the scenario is realistic.\n\nThe objective is to calculate the posterior probabilities of non–ST-elevation myocardial infarction (NSTEMI) given a positive or negative high-sensitivity cardiac troponin test result, denoted as $p(D\\mid T^{+})$ and $p(D\\mid T^{-})$ respectively. We are given the pretest probability $p(D) = 0.20$, the likelihood ratio for a positive test $\\text{LR+} = 8$, and the likelihood ratio for a negative test $\\text{LR-} = 0.2$. The task specifies starting from Bayes' theorem.\n\nBayes' theorem states that for two events $A$ and $B$, the conditional probability of $A$ given $B$ is:\n$$p(A\\mid B) = \\frac{p(B\\mid A)p(A)}{p(B)}$$\nIn our context, we are interested in $p(D\\mid T)$, where $T$ can be either $T^{+}$ or $T^{-}$. For a positive test, this is:\n$$p(D\\mid T^{+}) = \\frac{p(T^{+}\\mid D)p(D)}{p(T^{+})}$$\nThe denominator $p(T^{+})$ can be expanded using the law of total probability:\n$$p(T^{+}) = p(T^{+}\\mid D)p(D) + p(T^{+}\\mid \\neg D)p(\\neg D)$$\nwhere $\\neg D$ represents the absence of disease.\n\nA more direct way to incorporate likelihood ratios is to work with odds instead of probabilities. The odds of an event $A$ are defined as the ratio of the probability of the event occurring to the probability of it not occurring, $\\text{Odds}(A) = \\frac{p(A)}{1-p(A)}$.\n\nLet's derive the relationship between pretest odds, posterior odds, and the likelihood ratio starting from Bayes' theorem.\nThe posterior odds of disease given a positive test are $\\frac{p(D\\mid T^{+})}{p(\\neg D\\mid T^{+})}$.\nUsing Bayes' theorem for the numerator and denominator:\n$$p(D\\mid T^{+}) = \\frac{p(T^{+}\\mid D)p(D)}{p(T^{+})}$$\n$$p(\\neg D\\mid T^{+}) = \\frac{p(T^{+}\\mid \\neg D)p(\\neg D)}{p(T^{+})}$$\nDividing these two equations gives:\n$$\\frac{p(D\\mid T^{+})}{p(\\neg D\\mid T^{+})} = \\frac{p(T^{+}\\mid D)p(D)}{p(T^{+}\\mid \\neg D)p(\\neg D)} = \\left(\\frac{p(T^{+}\\mid D)}{p(T^{+}\\mid \\neg D)}\\right) \\times \\left(\\frac{p(D)}{p(\\neg D)}\\right)$$\nThe first term on the right is the definition of the likelihood ratio for a positive test, $\\text{LR+}$. The second term is the pretest odds of disease, $\\text{Odds}(D)$. Thus, we have the core relationship:\n$$\\text{Posterior Odds} = \\text{Likelihood Ratio} \\times \\text{Pretest Odds}$$\n\nFirst, we convert the given pretest probability $p(D) = 0.20$ into pretest odds:\n$$\\text{Pretest Odds} = \\text{Odds}(D) = \\frac{p(D)}{1-p(D)} = \\frac{0.20}{1-0.20} = \\frac{0.20}{0.80} = 0.25$$\n\nNow, we calculate the posterior odds for a positive test result ($T^{+}$) using $\\text{LR+} = 8$:\n$$\\text{Odds}(D\\mid T^{+}) = \\text{LR+} \\times \\text{Odds}(D) = 8 \\times 0.25 = 2.0$$\nTo find the posterior probability $p(D\\mid T^{+})$, we convert the posterior odds back to probability using the formula $p(A) = \\frac{\\text{Odds}(A)}{1+\\text{Odds}(A)}$:\n$$p(D\\mid T^{+}) = \\frac{\\text{Odds}(D\\mid T^{+})}{1+\\text{Odds}(D\\mid T^{+})} = \\frac{2.0}{1+2.0} = \\frac{2}{3}$$\nAs a decimal, this is approximately $0.66666...$. Rounding to four significant figures gives $0.6667$.\n\nNext, we calculate the posterior odds for a negative test result ($T^{-}$) using $\\text{LR-} = 0.2$:\n$$\\text{Odds}(D\\mid T^{-}) = \\text{LR-} \\times \\text{Odds}(D) = 0.2 \\times 0.25 = 0.05$$\nNow, we convert these posterior odds back to a probability:\n$$p(D\\mid T^{-}) = \\frac{\\text{Odds}(D\\mid T^{-})}{1+\\text{Odds}(D\\mid T^{-})} = \\frac{0.05}{1+0.05} = \\frac{0.05}{1.05} = \\frac{5}{105} = \\frac{1}{21}$$\nAs a decimal, this is approximately $0.047619...$. Rounding to four significant figures gives $0.04762$.\n\nThe calculated posterior probabilities are $p(D\\mid T^{+}) \\approx 0.6667$ and $p(D\\mid T^{-}) \\approx 0.04762$.\n\nThe final part of the task is to interpret these results.\nA positive test result significantly increases the probability of NSTEMI from a pretest value of $20\\%$ to a posterior probability of approximately $67\\%$. In clinical practice, a probability of this magnitude in a patient with chest discomfort crosses the threshold for treatment. This patient would be considered high-risk for an acute coronary syndrome. Immediate management would typically be initiated, including antiplatelet and anticoagulant therapy, beta-blockers, and nitrates as indicated. The patient would almost certainly be admitted to the hospital for monitoring, and coronary angiography would be strongly considered to visualize the coronary arteries and plan for potential revascularization.\n\nConversely, a negative test result substantially decreases the probability of NSTEMI from $20\\%$ to approximately $4.8\\%$. This low posterior probability is often considered sufficient to \"rule out\" an acute myocardial infarction, especially with a high-sensitivity assay. While a single negative result may not definitively exclude all risk, particularly in the very early hours after symptom onset, it moves NSTEMI much lower on the list of differential diagnoses. This result would support a decision to not initiate aggressive anti-ischemic therapy immediately. Depending on the specific clinical context and hospital protocol, this could lead to a second troponin measurement after a few hours to confirm the trend, or a shift in focus toward investigating other potential causes of the patient's symptoms (e.g., pulmonary embolism, aortic dissection, or non-cardiac causes). It significantly lowers the urgency for invasive testing like angiography.",
            "answer": "$$\n\\boxed{\\begin{pmatrix} 0.6667 & 0.04762 \\end{pmatrix}}\n$$"
        },
        {
            "introduction": "Diagnosis is rarely based on a single piece of data; it is an act of synthesis. However, a common cognitive error is to treat multiple findings as independent clues, incorrectly amplifying their collective diagnostic weight. This practice problem  addresses the crucial, real-world complexity of correlated findings, demonstrating why simply multiplying individual likelihood ratios can be profoundly misleading. You will learn to properly incorporate the combined weight of evidence using a joint likelihood ratio, a more accurate reflection of clinical reality.",
            "id": "4814907",
            "problem": "A clinician is evaluating a patient with suspected pulmonary embolism. Two clinical findings are present concurrently: unilateral calf swelling and resting tachycardia. Individually, these findings have positive Likelihood Ratios (LR) of $4$ and $3$, respectively. Because the findings arise from shared pathophysiology, they are positively correlated; an empirical study has shown that the joint positive LR for both findings present is $8$ rather than the multiplicative value $12$ that would be expected under conditional independence.\n\nThe clinician’s pretest probability for pulmonary embolism is $0.25$. Starting from the definitions of the Likelihood Ratio (LR) and Bayes’ theorem, derive the appropriate transformation from pretest probability to posterior probability using the joint LR, and then compute the posterior probability of pulmonary embolism given the two correlated findings. Express the final posterior probability as an exact fraction. Do not use percentage notation.",
            "solution": "The problem is first subjected to a validation process.\n\n### Step 1: Extract Givens\n-   Finding 1: Unilateral calf swelling. Individual positive Likelihood Ratio, $LR_1 = 4$.\n-   Finding 2: Resting tachycardia. Individual positive Likelihood Ratio, $LR_2 = 3$.\n-   Correlation: The two findings are positively correlated.\n-   Joint positive Likelihood Ratio for both findings present: $LR_{joint} = 8$.\n-   Pretest probability of pulmonary embolism: $P(\\text{disease}) = 0.25$.\n\n### Step 2: Validate Using Extracted Givens\nThe problem is assessed for validity based on the provided information.\n\n-   **Scientifically Grounded:** The problem is firmly rooted in the principles of Bayesian inference as applied to clinical diagnostics and epidemiology. The concepts of pretest probability, posterior probability, Likelihood Ratios, and the adjustment for correlated findings are standard and fundamental in evidence-based medicine. The numerical values provided are plausible for the clinical context of a suspected pulmonary embolism.\n-   **Well-Posed:** All necessary data ($LR_{joint}$ and pretest probability) are provided to calculate the posterior probability. The question is unambiguous and has a unique, stable mathematical solution.\n-   **Objective:** The problem is stated in precise, objective language without subjective or opinion-based claims.\n\n### Step 3: Verdict and Action\nThe problem is deemed **valid**. It is scientifically sound, well-posed, and objective. The solution process may proceed.\n\n---\n\nThe task is to derive the transformation from pretest to posterior probability using a Likelihood Ratio and then to compute the posterior probability for the given clinical scenario.\n\nLet $D$ be the event that the patient has the disease (pulmonary embolism), and let $D^c$ be the event that the patient does not have the disease. Let $E$ be the observation of the evidence, which in this case is the concurrent presence of both unilateral calf swelling and resting tachycardia.\n\nThe pretest probability is given as $P(D) = 0.25$. The pretest probability of not having the disease is therefore $P(D^c) = 1 - P(D) = 1 - 0.25 = 0.75$.\n\nThe goal is to find the posterior probability, $P(D|E)$, which is the probability of having the disease given the evidence.\n\nWe begin with the definition of Bayes' theorem:\n$$P(D|E) = \\frac{P(E|D) P(D)}{P(E)}$$\nThe term $P(E)$ in the denominator can be expanded using the law of total probability:\n$$P(E) = P(E|D) P(D) + P(E|D^c) P(D^c)$$\nSubstituting this into Bayes' theorem gives:\n$$P(D|E) = \\frac{P(E|D) P(D)}{P(E|D) P(D) + P(E|D^c) P(D^c)}$$\nThe positive Likelihood Ratio ($LR_+$) is defined as the ratio of the probability of observing the evidence in a patient with the disease to the probability of observing it in a patient without the disease. For the joint evidence $E$, this is the joint Likelihood Ratio, $LR_{joint}$:\n$$LR_{joint} = \\frac{P(E|D)}{P(E|D^c)}$$\nTo derive the required transformation from pretest probability $P(D)$ to posterior probability $P(D|E)$ using the $LR_{joint}$, we can manipulate the expanded Bayes' theorem. We divide the numerator and the denominator by $P(E|D^c)$:\n$$P(D|E) = \\frac{\\frac{P(E|D)}{P(E|D^c)} P(D)}{\\frac{P(E|D)}{P(E|D^c)} P(D) + \\frac{P(E|D^c)}{P(E|D^c)} P(D^c)}$$\nSubstituting the definition of $LR_{joint}$ and simplifying gives:\n$$P(D|E) = \\frac{LR_{joint} \\cdot P(D)}{LR_{joint} \\cdot P(D) + P(D^c)}$$\nSince $P(D^c) = 1 - P(D)$, the final form of the transformation is:\n$$P(D|E) = \\frac{LR_{joint} \\cdot P(D)}{LR_{joint} \\cdot P(D) + (1 - P(D))}$$\nThis equation provides the derived transformation from pretest probability to posterior probability.\n\nNow, we compute the posterior probability using the given values.\nThe problem states:\n-   Pretest probability, $P(D) = 0.25$. For an exact fractional answer, we use $P(D) = \\frac{1}{4}$.\n-   Joint Likelihood Ratio, $LR_{joint} = 8$.\n\nSubstituting these values into the derived formula:\n$$P(D|E) = \\frac{8 \\cdot \\frac{1}{4}}{8 \\cdot \\frac{1}{4} + (1 - \\frac{1}{4})}$$\nWe perform the arithmetic:\n$$P(D|E) = \\frac{2}{2 + \\frac{3}{4}}$$\nTo simplify the denominator, we find a common denominator:\n$$P(D|E) = \\frac{2}{\\frac{8}{4} + \\frac{3}{4}} = \\frac{2}{\\frac{11}{4}}$$\nFinally, we simplify the complex fraction:\n$$P(D|E) = 2 \\cdot \\frac{4}{11} = \\frac{8}{11}$$\nThus, the posterior probability of pulmonary embolism, given the two correlated findings, is $\\frac{8}{11}$.\n\nAlternatively, one can use the odds-form of Bayes' theorem.\nPretest odds are $Odds_{pre} = \\frac{P(D)}{1-P(D)} = \\frac{0.25}{0.75} = \\frac{1}{3}$.\nThe posterior odds are calculated by multiplying the pretest odds by the likelihood ratio:\n$Odds_{post} = LR_{joint} \\times Odds_{pre} = 8 \\times \\frac{1}{3} = \\frac{8}{3}$.\nThe posterior probability is then converted from the posterior odds:\n$P(D|E) = \\frac{Odds_{post}}{1 + Odds_{post}} = \\frac{\\frac{8}{3}}{1 + \\frac{8}{3}} = \\frac{\\frac{8}{3}}{\\frac{11}{3}} = \\frac{8}{11}$.\nBoth methods yield the same result.",
            "answer": "$$\\boxed{\\frac{8}{11}}$$"
        }
    ]
}